88 related articles for article (PubMed ID: 26733157)
21. Involvement of NANOG upregulation in malignant progression of human cells.
Li Y; Higashiyama S; Shimakage M; Kawahara K; Yutsudo M; Watari A
DNA Cell Biol; 2013 Mar; 32(3):104-10. PubMed ID: 23427894
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis.
Tommasi S; Zheng A; Yoon JI; Besaratinia A
Carcinogenesis; 2014 Aug; 35(8):1726-36. PubMed ID: 24480805
[TBL] [Abstract][Full Text] [Related]
23. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.
Fong H; Hohenstein KA; Donovan PJ
Stem Cells; 2008 Aug; 26(8):1931-8. PubMed ID: 18388306
[TBL] [Abstract][Full Text] [Related]
24. Malignant transformation of 293 cells induced by ectopic expression of human Nanog.
Lin YL; Han ZB; Xiong FY; Tian LY; Wu XJ; Xue SW; Zhou YR; Deng JX; Chen HX
Mol Cell Biochem; 2011 May; 351(1-2):109-16. PubMed ID: 21246261
[TBL] [Abstract][Full Text] [Related]
25. Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3.
Zhou Y; Li S; Huang Q; Xie L; Zhu X
J Mol Cell Biol; 2013 Aug; 5(4):239-49. PubMed ID: 23329853
[TBL] [Abstract][Full Text] [Related]
26. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
27. Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression.
You JS; Kang JK; Seo DW; Park JH; Park JW; Lee JC; Jeon YJ; Cho EJ; Han JW
Cancer Res; 2009 Jul; 69(14):5716-25. PubMed ID: 19567677
[TBL] [Abstract][Full Text] [Related]
28. DPPA5 Supports Pluripotency and Reprogramming by Regulating NANOG Turnover.
Qian X; Kim JK; Tong W; Villa-Diaz LG; Krebsbach PH
Stem Cells; 2016 Mar; 34(3):588-600. PubMed ID: 26661329
[TBL] [Abstract][Full Text] [Related]
29. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
30. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage.
Jackson SA; Olufs ZP; Tran KA; Zaidan NZ; Sridharan R
Stem Cell Reports; 2016 Mar; 6(3):302-11. PubMed ID: 26905202
[TBL] [Abstract][Full Text] [Related]
31. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
[TBL] [Abstract][Full Text] [Related]
32. Forced expression of Nanog in human bone marrow-derived endothelial cells activates other six pluripotent genes.
Picanço-Castro V; Russo-Carbolante E; Covas DT
Cell Reprogram; 2012 Jun; 14(3):187-92. PubMed ID: 22686476
[TBL] [Abstract][Full Text] [Related]
33. Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.
Verma R; Holland MK; Temple-Smith P; Verma PJ
Theriogenology; 2012 Jan; 77(1):220-8, 228.e1-2. PubMed ID: 22079579
[TBL] [Abstract][Full Text] [Related]
34. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
du Puy L; Lopes SM; Haagsman HP; Roelen BA
Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
[TBL] [Abstract][Full Text] [Related]
35. The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells.
Gawlik-Rzemieniewska N; Bednarek I
Cancer Biol Ther; 2016; 17(1):1-10. PubMed ID: 26618281
[TBL] [Abstract][Full Text] [Related]
36. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
37. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human.
Hart AH; Hartley L; Ibrahim M; Robb L
Dev Dyn; 2004 May; 230(1):187-98. PubMed ID: 15108323
[TBL] [Abstract][Full Text] [Related]
38. Nanog transforms NIH3T3 cells and targets cell-type restricted genes.
Piestun D; Kochupurakkal BS; Jacob-Hirsch J; Zeligson S; Koudritsky M; Domany E; Amariglio N; Rechavi G; Givol D
Biochem Biophys Res Commun; 2006 Apr; 343(1):279-85. PubMed ID: 16540082
[TBL] [Abstract][Full Text] [Related]
39. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
